title: Targeted Therapy Makes Inroads in Medulloblastoma.
authors.forename: Charlie
authors.initials: C
authors.lastname: Schmidt
mesh_terms: D000813:Anilides / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001478:Basal Cell Nevus Syndrome / Q000378:metabolism; D002528:Cerebellar Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D004345:Drug Industry; D005060:Europe; D006801:Humans; D008527:Medulloblastoma / Q000188:drug therapy* / Q000378:metabolism; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends; D009656:North America; D000072079:Patched Receptors; D011725:Pyridines / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; C538724:HhAntag691; D000072079:Patched Receptors; D011725:Pyridines; D011956:Receptors, Cell Surface